Search Results 1291-1300 of 18718 for Relapse
The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...
... Relapsed Favorable Histology Wilms Tumors A Study of Combination ... (relapsed). Drugs used in chemotherapy regimens such as UH-3 (vincristine ...
Journalists: sound bites with Dr. Mielke are available in the downloads. Root Cause of Multiple Myeloma Relapse Revealed · Caring Canines Bring ...
Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Eau Claire, Wis., Mankato, Minn., La Crosse, Wis., ...
A Study in Subjects With Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination With Dexamethasone ...
... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...
Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...
leukemia in first relapse following ≥ 1 unsuccessful salvage attempts;; leukemia in second or higher relapse; or; patients who are not candidates for ...
... relapse of Crohn's disease after surgical resection. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year Rochester, MN. The purpose of this ...
The purpose of this study is to determine how safe and how well POL-103A works in preventing the relapse of melanoma after patients who have undergone surgery.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.